Verisante Technology Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Verisante Technology Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12114
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verisante Technology Inc (Verisante) is a medical device company that develops and commercializes systems for the early detection of cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a multispectral imaging camera used in the detection of oral and skin cancer. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. The company is ISO 13485:2003 certified. Verisante is headquartered in Richmond, British Columbia, Canada.

Verisante Technology Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verisante Technology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verisante Technology Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Verisante Technology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verisante Technology Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Verisante Technology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Verisante Technology Inc, Medical Equipment, Deal Details 10
Partnerships 10
Verisante Plans to Form Joint Venture with Astoria Capital 10
Verisante Technology Enters Into Agreement With BC Cancer Agency And Fujian Normal University 11
Verisante to Enter into Licensing Agreement to Develop Core Device for Lung Cancer 12
Equity Offering 13
Verisante Technology Raises USD0.08 Million in Private Placement of Shares 13
Verisante Technology Raises USD0.3 Million in Private Placement of Shares 14
Verisante Raises USD0.27 Million in Private Placement of Shares 15
Verisante Raises USD0.27 Million in Private Placement of Shares 16
Verisante Technology Completes Private Placement Of Units For US$0.4 Million 17
Verisante Technology Completes Private Placement Of Units For US$1 Million 18
Verisante Technology Completes Private Placement Of Units For US$0.92 Million 19
Verisante Technology Announces Private Placement Of Units In US For Up To US$5 Million 20
Acquisition 21
Verisante Technology To Acquire SIM In Reverse Takeover Transaction For Approximately US$39.7 Million 21
Verisante Technology Inc – Key Competitors 22
Verisante Technology Inc – Key Employees 23
Verisante Technology Inc – Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Verisante Technology Inc, Medical Equipment, Key Facts 2
Verisante Technology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Verisante Technology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verisante Technology Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Verisante Technology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verisante Technology Inc, Deals By Market, 2012 to YTD 2018 8
Verisante Technology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Verisante Plans to Form Joint Venture with Astoria Capital 10
Verisante Technology Enters Into Agreement With BC Cancer Agency And Fujian Normal University 11
Verisante to Enter into Licensing Agreement to Develop Core Device for Lung Cancer 12
Verisante Technology Raises USD0.08 Million in Private Placement of Shares 13
Verisante Technology Raises USD0.3 Million in Private Placement of Shares 14
Verisante Raises USD0.27 Million in Private Placement of Shares 15
Verisante Raises USD0.27 Million in Private Placement of Shares 16
Verisante Technology Completes Private Placement Of Units For US$0.4 Million 17
Verisante Technology Completes Private Placement Of Units For US$1 Million 18
Verisante Technology Completes Private Placement Of Units For US$0.92 Million 19
Verisante Technology Announces Private Placement Of Units In US For Up To US$5 Million 20
Verisante Technology To Acquire SIM In Reverse Takeover Transaction For Approximately US$39.7 Million 21
Verisante Technology Inc, Key Competitors 22
Verisante Technology Inc, Key Employees 23

List of Figures
Verisante Technology Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Verisante Technology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Verisante Technology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Verisante Technology Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Verisante Technology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verisante Technology Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Verisante Technology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verisante Technology Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Verisante Technology Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GW Pharmaceuticals Plc (GWP):企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Twenty-First Century Fox, Inc.:企業の戦略・SWOT・財務情報
    Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report Summary Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Allinky Biopharma SL:医療機器:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …
  • Rosseti (RSTI):企業の財務・戦略的SWOT分析
    Rosseti (RSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Vikas WSP Ltd (519307):企業の財務・戦略的SWOT分析
    Vikas WSP Ltd (519307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Bajaj Corp Limited:戦略・SWOT・企業財務分析
    Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • North Central Electric Cooperative, Inc.:発電所・企業SWOT分析
    North Central Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informa …
  • Fluor Corporation (FLR):企業の財務・戦略的SWOT分析
    Fluor Corporation (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Shunfeng International Clean Energy Ltd (1165):電力:M&Aディール及び事業提携情報
    Summary Shunfeng International Clean Energy Ltd (Shunfeng International), formerly Shunfeng Photovoltaic International Ltd is a renewable energy company that manufactures and markets solar photovoltaic products. The company’s products include monocrystalline silicon solar cells, polycrystalline sili …
  • Ineos Group AG:企業の戦略的SWOT分析
    Ineos Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bankers Petroleum Ltd:企業の戦略的SWOT分析
    Bankers Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • The Netherlands Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • Kallpa Generacion SA:企業の戦略的SWOT分析
    Kallpa Generacion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • California Pizza Kitchen, Inc.:企業の戦略・SWOT・財務分析
    California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report Summary California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nestle Health Science SA:企業のM&A・事業提携・投資動向
    Nestle Health Science SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nestle Health Science SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Atlas Consolidated Mining and Development Corporation:企業の戦略・SWOT・財務情報
    Atlas Consolidated Mining and Development Corporation - Strategy, SWOT and Corporate Finance Report Summary Atlas Consolidated Mining and Development Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆